secwatch.observer — SEC 8-K summary
======================================

Issuer:     U S PHYSICAL THERAPY INC /NV (USPH)
CIK:        0000885978
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0000885978-24-000005
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USPH Q4 net loss $0.7M ($0.38/share) on $17.5M impairment; FY Adj EBITDA $77.7M; 2024 guide $80-85M
--------------------------------------------------------------------------------

- Net income FY2023 $28.2M ($1.28/share) vs $32.2M ($2.25/share) in FY2022; non-GAAP Op Results $36.3M ($2.56/share).
- Record patient visits in FY2023 of 5.0M (+11.6%); total clinics 671 as of Dec 31, 2023 (46 added, 15 closed).
- Q4 2023 total net revenue $154.8M (+9.6%); gross profit $30.5M; GAAP loss per share $0.38 due to $17.5M impairment.
- Board raised quarterly dividend to $0.44/share from $0.43; payable Apr 5, 2024 to record Mar 12, 2024.
- 2024 Adjusted EBITDA guided at $80-85M; expects to offset ~$6M Medicare rate cut via rate negotiations, volume growth, & acquisitions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885978/000088597824000005/0000885978-24-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885978/000088597824000005/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0000885978-24-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer